ConductScience.org, home

Paper35866252

Advances in 3D Bioprinting for Cancer Biology and Precision Medicine: From Matrix Design to Application.

Jung M and 4 others. Adv Healthc Mater, 2022. Cited by 52 papers, by iCite.

Cite this record

ConductScience Library. Advances in 3D Bioprinting for Cancer Biology and Precision Medicine: From Matrix Design to Application. Papers, record 35866252. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35866252

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Advances in 3D Bioprinting for Cancer Biology and Precision Medicine: From Matrix Design to Application.
PubMed
Journal
Adv Healthc Mater
PubMed
Year
2022
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
52
iCite
Relative citation ratio, by iCite
3.86
iCite
Revised in PubMed
2026-09-23
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BioprintingMajor topic
NeoplasmsMajor topic
Humans
Precision Medicine
Printing, Three-Dimensional
Biology
Tissue Engineering
Tissue Scaffolds
Tumor Microenvironment

Source PubMed

Download CSV of topics

References131

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117535867Changes in calf muscle elasticity in hypogonadal males before and after testosterone substitution as monitored by magnetic resonance elastography.Eur J Endocrinol2007https://conductscience.org/library/papers/17535867PubMed
228331002Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine.Cancer Discov2017https://conductscience.org/library/papers/28331002PubMed
319931152Matrix crosslinking forces tumor progression by enhancing integrin signaling.Cell2009https://conductscience.org/library/papers/19931152PubMed
432775607Hydrogel-based 3D bioprinting: A comprehensive review on cell-laden hydrogels, bioink formulations, and future perspectives.Appl Mater Today2020https://conductscience.org/library/papers/32775607PubMed
530413828The clinical role of the TME in solid cancer.Br J Cancer2019https://conductscience.org/library/papers/30413828PubMed
633089109A 3D Bioprinter Specifically Designed for the High-Throughput Production of Matrix-Embedded Multicellular Spheroids.iScience2020https://conductscience.org/library/papers/33089109PubMed
726696527A simple and high-resolution stereolithography-based 3D bioprinting system using visible light crosslinkable bioinks.Biofabrication2015https://conductscience.org/library/papers/26696527PubMed
829562660Erratum: Roche, J. The Epithelial-to-Mesenchymal Transition in Cancer. Cancers, 2018, 10, 52.Cancers (Basel)2018https://conductscience.org/library/papers/29562660PubMed
919217873Rheology and confocal reflectance microscopy as probes of mechanical properties and structure during collagen and collagen/hyaluronan self-assembly.Biophys J2009https://conductscience.org/library/papers/19217873PubMed
1032843638The updated landscape of tumor microenvironment and drug repurposing.Signal Transduct Target Ther2020https://conductscience.org/library/papers/32843638PubMed
1122159717The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.Mol Cell Proteomics2012https://conductscience.org/library/papers/22159717PubMed
1221376230Hallmarks of cancer: the next generation.Cell2011https://conductscience.org/library/papers/21376230PubMed
13345563403D-bioprinted cancer-on-a-chip: level-up organotypic in vitro models.Trends Biotechnol2022https://conductscience.org/library/papers/34556340PubMed
1434927798In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancer.EMBO Mol Med2022https://conductscience.org/library/papers/34927798PubMed
1533672626Natural Biomaterials and Their Use as Bioinks for Printing Tissues.Bioengineering (Basel)2021https://conductscience.org/library/papers/33672626PubMed
1631148598A bioprinted human-glioblastoma-on-a-chip for the identification of patient-specific responses to chemoradiotherapy.Nat Biomed Eng2019https://conductscience.org/library/papers/31148598PubMed
1730459432Assessing the elastic properties of skeletal muscle and tendon using shearwave ultrasound elastography and MyotonPRO.Sci Rep2018https://conductscience.org/library/papers/30459432PubMed
1827123816A practical guide to hydrogels for cell culture.Nat Methods2016https://conductscience.org/library/papers/27123816PubMed
19339125513D Cancer Models: The Need for a Complex Stroma, Compartmentalization and Stiffness.Front Bioeng Biotechnol2021https://conductscience.org/library/papers/33912551PubMed
2020162561Matrigel: a complex protein mixture required for optimal growth of cell culture.Proteomics2010https://conductscience.org/library/papers/20162561PubMed

See all 131 referencesDownload CSV of references

Cited by35

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.

PMIDTitleJournalYearIn PapersSource
42602561dECM bioinks for 3D bioprinted tumor models: Advances, challenges, and drug screening.iScience2026https://conductscience.org/library/papers/42602561PubMed
42536735Stiff matrix impairs cytotoxic T lymphocyte function at multiple levels.Sci Adv2026https://conductscience.org/library/papers/42536735PubMed
42328780Matrix Stiffness Directs Stemness Signatures in Breast Cancer.Adv Healthc Mater2026https://conductscience.org/library/papers/42328780PubMed
42256398Exploiting signal transduction pathways for cancer therapy: insights from natural products in preclinical models.Front Pharmacol2026https://conductscience.org/library/papers/42256398PubMed
42032323Engineering macrophages for cancer immunotherapy: emerging insights and therapeutic potential.NPJ Biomed Innov2026https://conductscience.org/library/papers/42032323PubMed
41828336The Future of Breast Cancer Treatment: From Conventional Wisdom to Nanotechnology-Enabled Precision.Int J Mol Sci2026https://conductscience.org/library/papers/41828336PubMed
41761263Recapitulating the tumour microenvironment: advancing personalised radiation therapy through organoid technology.J Exp Clin Cancer Res2026https://conductscience.org/library/papers/41761263PubMed
41491196Tumor-on-chip's alliance with molecular pathology against metastatic disease.J Biomed Sci2026https://conductscience.org/library/papers/41491196PubMed
41440181High-Throughput 3D Bioprinted Organoids of Skin Cancer Utilized for Diagnosis and Personalized Therapy.Curr Oncol2025https://conductscience.org/library/papers/41440181PubMed
41413532Three-dimensional bioprinting of patient-derived Gastrointestinal stromal tumor: a novel platform for precision oncology and drug response profiling.J Nanobiotechnology2025https://conductscience.org/library/papers/41413532PubMed
41158775From mechanisms to precision medicine: the role of organoids in studying the gut microbiota-tumor microenvironment axis.Front Microbiol2025https://conductscience.org/library/papers/41158775PubMed
41085522A 3D Bioprinted Pancreatic Cancer Model Using Collagen-Gelatin Methacrylamide-Alginate Bioinks to Mimic the Desmoplastic Microenvironment.Biomacromolecules2025https://conductscience.org/library/papers/41085522PubMed
41050078Cancer 3D Models: Essential Tools for Understanding and Overcoming Drug Resistance.Oncol Res2025https://conductscience.org/library/papers/41050078PubMed
40733293Applications and Recent Advances in 3D Bioprinting Sustainable Scaffolding Techniques.Molecules2025https://conductscience.org/library/papers/40733293PubMed
40591169Tumor-infiltrating nerves: unraveling the role of cancer neuroscience in tumorigenesis, disease progression, and emerging therapies.Discov Oncol2025https://conductscience.org/library/papers/40591169PubMed
39697234Advances in the application of colorectal cancer organoids in precision medicine.Front Oncol2024https://conductscience.org/library/papers/39697234PubMed
39242807A translational framework to DELIVER nanomedicines to the clinic.Nat Nanotechnol2024https://conductscience.org/library/papers/39242807PubMed
39205873Advanced tumor organoid bioprinting strategy for oncology research.Mater Today Bio2024https://conductscience.org/library/papers/39205873PubMed
39169896The potential of hydrogel-free tumoroids in head and neck squamous cell carcinoma.Cancer Med2024https://conductscience.org/library/papers/39169896PubMed
38896849Advancing Synthetic Hydrogels through Nature-Inspired Materials Chemistry.Adv Mater2024https://conductscience.org/library/papers/38896849PubMed

See all 35 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35866252

GET https://conductscience.org/api/papers/v1/35866252/references?page=2